PAVmed Analyst Ratings
PAVmed Analyst Ratings
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a reiterated with a price target of $0.00 to $1.40. The current price PAVmed (PAVM) is trading at is $0.25, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 467.03% | Cantor Fitzgerald | → $1.4 | Reiterates | Neutral → Neutral |
| 01/20/2023 | 507.53% | Cantor Fitzgerald | $4 → $1.5 | Downgrades | Overweight → Neutral |
| 01/18/2023 | 507.53% | Lake Street | $5 → $1.5 | Maintains | Buy |
| 08/17/2022 | 1925.11% | Lake Street | $7 → $5 | Maintains | Buy |
| 03/30/2021 | 3140.18% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 1925.11% | Ascendiant Capital | → $5 | Initiates Coverage On | → Buy |
| 10/13/2020 | 1925.11% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/18/2023 | 467.03% | 坎託·菲茨傑拉德 | → 1.4 美元 | 重申 | 中性 → 中性 |
| 01/20/2023 | 507.53% | 坎託·菲茨傑拉德 | 4 美元 → 1.5 美元 | 降級 | 超重 → 中性 |
| 01/18/2023 | 507.53% | 湖街 | 5 美元 → 1.5 美元 | 維護 | 購買 |
| 08/17/2022 | 1925.11% | 湖街 | 7 美元 → 5 美元 | 維護 | 購買 |
| 03/30/2021 | 3140.18% | 坎託·菲茨傑拉德 | → 8 美元 | 啓動覆蓋開啓 | → 超重 |
| 2020 年 5 月 11 日 | 1925.11% | 上升資本 | → 5 美元 | 啓動覆蓋開啓 | → 購買 |
| 2020 年 10 月 13 日 | 1925.11% | 湖街 | → 5 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for PAVmed (PAVM)?
PavMed（PAVM）的目標價格是多少？
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Cantor Fitzgerald on August 18, 2023. The analyst firm set a price target for $1.40 expecting PAVM to rise to within 12 months (a possible 467.03% upside). 3 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年8月18日公佈了PavMed（納斯達克股票代碼：PAVM）的最新目標股價。該分析公司將目標股價定爲1.40美元，預計PAVM將在12個月內升至1.40美元（可能上漲467.03％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for PAVmed (PAVM)?
PavMed (PAVM) 的最新分析師評級是多少？
The latest analyst rating for PAVmed (NASDAQ: PAVM) was provided by Cantor Fitzgerald, and PAVmed reiterated their neutral rating.
PavMed（納斯達克股票代碼：PAVM）的最新分析師評級由坎託·菲茨傑拉德提供，PavMed重申了中性評級。
When is the next analyst rating going to be posted or updated for PAVmed (PAVM)?
PavMed（PAVM）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與PavMed的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。PavMed的最後一次評級是在2023年8月18日提交的，因此你應該預計下一個評級將在2024年8月18日左右公佈。
Is the Analyst Rating PAVmed (PAVM) correct?
分析師評級 PavMed (PAVM) 是否正確？
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a reiterated with a price target of $0.00 to $1.40. The current price PAVmed (PAVM) is trading at is $0.25, which is within the analyst's predicted range.
雖然評級是主觀的，並且會發生變化，但重申了最新的PavMed（PAVM）評級，目標股價爲0.00美元至1.40美元。PavMed（PAVM）的當前交易價格爲0.25美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
